Parakkal Deepak, MD
Gastroenterology · Saint Louis, MONPI 1972811974
Payments from drug & device makers
Across 406 payments — averaging $5033.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$551K
- Bristol Myers Squibb$434K
- Teva Pharmaceuticals USA, Inc.$245K
- E.r. Squibb & Sons, L.L.C.$177K
- Pfizer$139K
- AbbVie$115K
- plus $383K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $550,714 |
| Bristol Myers Squibb | 47 | $434,013 |
| Teva Pharmaceuticals USA, Inc. | 28 | $245,023 |
| E.r. Squibb & Sons, L.L.C. | 17 | $176,915 |
| Pfizer(2 entities) | 105 | $138,587 |
| AbbVie(2 entities) | 60 | $115,446 |
| Boehringer Ingelheim | 3 | $85,129 |
| Sanofi US Services Inc. | 2 | $66,252 |
| Johnson & Johnson | 45 | $55,796 |
| Boehringer Ingelheim International GmbH | 6 | $40,168 |
| Janssen Research & Development, LLC | 5 | $34,110 |
| Eli Lilly | 10 | $26,755 |
| Sobi, Inc | 10 | $12,137 |
| Janssen Scientific Affairs, LLC | 9 | $11,805 |
| Astrazeneca UK Limited | 1 | $11,762 |
| Hexal AG | 2 | $9,113 |
| Merck | 9 | $8,525 |
| Celltrion USA Inc. | 6 | $8,275 |
| Lilly USA, LLC | 2 | $4,950 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 4 | $4,922 |
| Genentech, Inc. | 1 | $2,415 |
| Fresenius Kabi USA, LLC | 1 | $610 |
| Cordis US CORP. | 1 | $86 |
| Mindray DS USA, Inc. | 2 | $82 |
| Samsung HME America, Inc. | 1 | $50 |
| Shire North American Group Inc | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$2,043,674 in reported general payments places this provider in the 95th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Saint Louis
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$920K
- Kevin KorenblatSaint Louis$857K
- Brent Neuschwander-TetriSaint Louis$729K
- David AlpersSaint Louis$616K
- Chandra GyawaliSaint Louis$593K
- Richard RoodSaint Louis$567K
- Matthew CiorbaSaint Louis$551K
- Bruce BaconSaint Louis$307K
- Wing-Kin SynSaint Louis$283K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.